C
CIN Terminal
Cannabis Investor News
A CanIDeal, Inc. Company
J
Live
Loading market data...
Expand
Symbol Name Exchange Last Change Volume Watch
Home Markets Loading…
BRMHF Equity

BRMHF

OTCMKTS · BRMHF

Live Price
Price History 5 Years

Analyst Coverage

Cannabis Investor News in-house rating · cin-analyst-v1.0

Neutral Conviction 3/5
41/100 composite
Fundamentals40
Regulatory49
Market40
Editorial30
Composite · trailing 12 months

Cannabist Company Holdings holds a Neutral rating within its band, stemming from balanced contributions across fundamental, regulatory, and market pillars. Notably, the regulatory pillar is the strongest driver with a contribution of 49.0, showcasing the firm's compliance and stability within its jurisdiction, despite the lack of recent regulatory events over the past 90 or 180 days. The fundamentals and market aspects present uncertainties due to the absence of available financial and market data, limiting visibility into the company's financial health and positioning relative to peers. Editorial factors show minimal impact, reflected in the low presence in newsroom or brief hits.

A detailed examination of underlying data points reveals no available information on Cannabist's revenue, margins, or financial condition, which hampers a comprehensive assessment of its business operations. The firm's regulatory environment shows significant resilience with zero enforcement hits, which bolsters confidence in legal compliance. Filings cadence, however, remains a concern with limited updates, impacting the overall regulatory stature. Market evaluation is notably hindered by the absence of quote availability, further adding to the opacity in assessing competitive standing and investor sentiment.

Looking ahead, the critical catalyst lies in Cannabist's regulatory environment, specifically its ability to maintain enforcement-free compliance while improving filing cadence. As it operates under US jurisdiction, closely monitoring any prospective regulatory developments can offer valuable insights. Enhanced consistency and transparency in regulatory filings could set a foundation for strengthening investor confidence and elevating the company's composite outlook, making this pillar a key focus area for stakeholders.

Scored: 2026-08-24Valid through: 2026-10-08Weights: Fundamentals 35% · Regulatory 25% · Market 25% · Editorial 15%
Loading CIN Rating…
Fundamentals SEC & Market Data
Loading fundamentals…
Analyst Consensus
Loading analyst data…
Valuation Multiples
Loading…
Price Statistics
Loading…
Financing Activity
Loading financing data…
Insider Transactions
Loading insider data…
Regulatory Filings
Loading regulator disclosures…
Peer Comparison
Loading peer data…
Institutional DetailIR, corporate, and filing data from CIN enrichment
Corporate DetailsCompany profile
Filings & DisclosuresPrimary sources
Filing portal
SEC EDGAR
See something incorrect or missing?

Help us keep coverage accurate. Submit an update for CIN editorial review.

Submit an update
Complimentary Research
Would you like a deeper analysis on this company?

Request a complimentary, fully customized institutional-quality research report — tailored to your investment thesis.

Request Complimentary Report

Bullish and Bearish Analyst Opinions for BRMHF (BRMHF)

Cannabis Investor News aggregates analyst coverage, price targets, insider transactions, SEC filings, and financing activity for BRMHF (BRMHF), a cannabis-sector equity listed on OTCMKTS. Use this profile to compare bullish and bearish opinions, monitor Form 4 insider buys and sells, and review the latest quarterly results.

CIN editorial stance: Neutral / Wait. Mixed data profile. Await clearer directional signal. (0 bullish signals, 0 bearish signals.)

Historical Price Data

5-year weekly price history, intraday quotes, and 52-week range for BRMHF are maintained by Cannabis Investor News and refreshed throughout the trading day.